Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
-
Inogen Announces Third Quarter 2024 Financial Results
-
Golden Entertainment Reports 2024 Third Quarter Results
-
Affirm Reports First Fiscal Quarter 2025 Results
-
Kura Oncology Reports Third Quarter 2024 Financial Results
-
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Amprius Technologies Reports Third Quarter 2024 Business and Financial Results
-
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
-
Jeff’s’ Brands Initiates Strategic Plan by Entering into a Non-Binding Letter of Intent to Sell Subsidiary to a U.S. Public Company at a valuation of approximately $13.125 million
-
Lifetime Brands, Inc. Reports Third Quarter 2024 Financial Results
-
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
-
Ecolab Schedules Webcast of Industry Conference for November 13, 2024
-
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
-
RxSight, Inc. Reports Third Quarter 2024 Financial Results
-
CarGurus Announces Third Quarter 2024 Results
-
Santander Bank Lowers Its Prime Rate to 7.75%
-
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 13, 2024
-
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
-
Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2025 Financial Results
-
KEYCORP LOWERS ITS PRIME LENDING RATE TO 7.75 PERCENT
-
Dropbox Announces Fiscal 2024 Third Quarter Results
-
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations
-
Lumentum Announces Fiscal First Quarter 2025 Financial Results
-
AVITA Medical Reports Third Quarter Financial Results
-
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
-
Innovex Announces Third-Quarter 2024 Results
-
PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028
-
Jennifer Lowry to Join the Board of Directors of TPI Composites, Inc.
-
Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Alarm.com Reports Third Quarter 2024 Results
-
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
-
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
-
Green Thumb Industries Reports Third Quarter 2024 Results
-
Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
-
Collegium Reports Record Third Quarter 2024 Financial Results
-
Sasquatch Resources Announces Results of Exploration on Blue Grouse Property
-
Iodine Software Ranked #1 in Client Satisfaction for AI-powered Mid-Revenue Cycle Management Solutions in Black Book Research User Survey
-
Sunrun Reports Third Quarter 2024 Financial Results
-
Travere Therapeutics Announces Proposed Public Offering of Common Stock
-
Verizon announces tender offers for six series of debt securities
-
Ascendis Pharma to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
-
BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress
-
AKAMAI REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
-
Expedia Group Reports Third Quarter 2024 Results
-
Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
-
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
-
Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency¹)
-
Axon reports Q3 2024 revenue of $544 million, up 32% year over year, raises outlook
-
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
